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Abstract
Introduction 
Practice-Based Research Networks (PBRNs) and health systems may provide timely, reliable data to guide the 
development and distribution of public health resources to promote healthy behaviors, such as quitting smoking. The 
objective of this study was to determine if PBRN data could be used to make neighborhood-level estimates of smoking 
prevalence.
Methods 
We estimated the smoking prevalence in 32 greater Boston neighborhoods (population = 877,943 adults) by using the 
electronic health record data of adults who in 2009 visited one of 26 Partners Primary Care PBRN practices (n = 
77,529). We compared PBRN-derived estimates to population-based estimates derived from 1999–2009 Behavioral 
Risk Factor Surveillance System (BRFSS) data (n = 20,475).
Results 
The PBRN estimates of neighborhood smoking status ranged from 5% to 22% and averaged 11%. The 2009 
neighborhood-level smoking prevalence estimates derived from the BRFSS ranged from 5% to 26% and averaged 13%. 
The difference in smoking prevalence between the PBRN and the BRFSS averaged −2 percentage points (standard 
deviation, 3 percentage points).
Conclusion 
Health behavior data collected during routine clinical care by PBRNs and health systems could supplement or be an 
alternative to using traditional sources of public health data.
Introduction
Population distribution measurements of health indicators for chronic diseases can be used to target health care and 
community resources to areas with greatest need. The Centers for Disease Control and Prevention (CDC) and state 
health departments expend time, money, and energy measuring the distribution of health conditions and behavioral 
risk factors throughout the United States. The Behavioral Risk Factor Surveillance System (BRFSS), a cornerstone of 
these efforts with an annual budget of about $15 million, collects data on smoking, weight, diet, exercise, preventive 
medical care, and other behaviors (1,2). However, the BRFSS was designed to provide stable estimates at the 
metropolitan and state levels; because of limited sample sizes, creating stable estimates at the neighborhood level 
requires complex modeling and pooling several years of data (3).
Practice-based research networks (PBRNs) and integrated health delivery systems also collect patient behavioral 
health data in the course of routine clinical care (4,5). With increasing use of electronic health records (EHRs), 
behavioral data are more commonly available in standard formats (6). Data from larger health systems and PBRNs 
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factors.
Tobacco use remains the leading cause of preventable death in the United States (7). Knowledge about neighborhood-
level smoking prevalence is necessary to guide the efficient deployment of community-based resources. Patient 
smoking status is routinely recorded in EHRs; EHR data derived from PBRNs and health systems may provide 
accurate community-level estimates of the prevalence of tobacco use. To determine if PBRN data could be used to 
make reasonable neighborhood-level estimates of smoking prevalence, we compared PBRN data to population-based, 
neighborhood-level estimates of smoking prevalence derived from the BRFSS.
Methods
Overview
Our analysis focused on 32 neighborhoods in the greater Boston area that corresponded to the catchment area of the 
Partners Primary Care PBRN. We compared population-based smoking prevalence estimates derived from the BRFSS 
and the US Census with 2009 prevalence estimates derived from the Partners Primary Care PBRN. We limited our 
analysis to respondents and patients aged 18 years or older. The Partners Human Research Committee approved the 
study protocol.
Data extraction and data analysis
Three population-based smoking prevalence estimates
We derived individual-level data for population-based smoking prevalence estimates from the BRFSS, a population-
based telephone survey administered by the CDC and state health departments (1). The BRFSS was designed for 
statewide or metropolitan area use and has been a primary source of population-based information on the prevalence 
of smoking. As part of the random-digit–dial survey, the BRFSS asks respondents, “Have you smoked 100 cigarettes in 
your lifetime?” and, if yes, “Do you currently smoke cigarettes?” We included annual population-based data from 1999 
through 2009 for respondents who were at least 18 years old and living in 1 of the 32 neighborhoods in the Partners 
Primary Care PBRN catchment area, based on census tracts. The response rate for the BRFSS in Massachusetts in 
2009 was 48%. Community-level data were derived from the 2000 Census.
We combined individual-level data from the BRFSS and community-level data from the US Census to estimate 
community-level smoking prevalence using a mixed-effects logistic regression model described previously (3). To 
summarize, using data from 1999 to 2009, the model predicted the prevalence of smoking in each of the 32 five-digit 
zip code levels in 2009. The model included 7 individual-level characteristics (age, sex, race/ethnicity, marital status, 
education level, employment, and annual household income), 8 community-level characteristics (median per capita 
income, percentage of owner-occupied housing units, percentage of blue-collar jobs in the total employed labor force, 
racial diversity, percentage of vacant housing units, percentage of population in rural area, crude rate of admission to 
Department of Public Health–funded substance abuse treatment programs, and density of tobacco outlets [number 
measured per mile of road]), and the year of interview.
Three PBRN-based smoking prevalence estimates
The Partners Primary Care PBRN includes 23 practices in eastern Massachusetts affiliated with Brigham and Women’s 
Hospital or Massachusetts General Hospital. The 23 practices include 5 hospital-based practices, 12 community-based 
practices, and 6 community health centers. We included patients aged at least 18 who made at least 1 visit to 1 of these 
PBRN practices in 2009 and had a zip code in 1 of the 32 neighborhoods in the catchment area of the PBRN. The 
Partners Primary Care PBRN practices use the Longitudinal Medical Record, an internally developed, web-based, fully 
functional EHR (8). We assessed smoking status using the EHR patient problem list and the health monitoring 
module, which contains concepts about health behaviors, prevention, and chronic disease monitoring. Information is 
entered into the problem list and health monitoring module by various members of the health care team.
We calculated the practice-based smoking prevalence and the frequency with which smoking status was not 
documented. We calculated the “market share” of the Partners Primary Care PBRN in each of the 32 neighborhoods by 
dividing the number of PBRN patients by the US Census population 18 years or older in that neighborhood.
We estimated neighborhood smoking prevalence in 2 ways using PBRN data. First, we calculated the crude prevalence 
of smoking in the PBRN data in each neighborhood by dividing the number of smokers by the total number of patients 
— smokers, nonsmokers, and patients with undocumented smoking status — from that neighborhood. Second, we 
calculated the smoking prevalence standardized by the neighborhood makeup according to the 2000 US census using 
age in 4 categories (18–39, 40–59, 60–79, or ≥80), sex, and race/ethnicity in 4 categories (white, Latino, black, or 
other). There were no patients in 71 of 1,024 cells. To make standardized estimates for these cells, we calculated 
predicted probabilities using a logistic regression model with smoking as the outcome and 2-way and 3-way 
interactions between age, sex, and race/ethnicity. We then filled the empty cells by calculating a smoothed estimate of 
Page 2 of 10 Preventing Chronic Disease | Use of Practice-Based Research Network Data to Measure ...the smoking prevalence by fitting the same logistic regression model but leaving out the 3-way interaction term for that 
cell.
Statistical analysis
For BRFSS data, we calculated 95% confidence intervals using the variances of the random effects from the logistic 
regression model. For the PBRN data, we calculated exact binomial 95% confidence intervals. Because of the large 
sample sizes and our interest in how similar the prevalence of smoking was, we relied on clinical significance rather 
than formal statistical testing. For ease of interpretation and because smaller increments are unlikely to be clinically 
significant and may give a false sense of precision, we rounded all proportions to the nearest whole percentage. We 
assessed the relationship between the practice at which patients were seen and the neighborhood in which they lived 
using Cramer’s V. We considered a Cramer’s V, which can range from 0 to 1, of 0.25 or higher a strong relationship (9). 
We used ArcMap 10.0 (ESRI, Redlands, California) to generate maps, Stata 11.0 (StataCorp, LP, College Station, 
Texas) to obtain BRFSS population-based estimates, and SAS 9.2 (SAS Institute Inc, Cary, North Carolina) to calculate 
PBRN-based estimates.
Results
Sample sizes and characteristics
According to the US Census, 877,943 adults lived in the 32 neighborhoods in 2009 (population range across 
neighborhoods, 4,143–60,028). From 1999 to 2009, there were 20,475 adult BRFSS respondents who lived in the 
target area of interest used to estimate 2009 smoking prevalence (sample range across neighborhoods, 85–1,731).
There were 77,516 adult patients seen in the Partners Primary Care PBRN in 2009 who lived in 1 of the 32 
neighborhoods (range across neighborhoods, 430–7,960). There was a strong relationship between the practice 
patients attended and neighborhood in which they lived (Cramer’s V, 0.33). Compared with census-determined 
characteristics, adults seen in Partners PBRN practices were more likely to be older, female, and Latino (Table 1).
Practice-based smoking documentation
Overall, 12% of patients seen at the Partners PBRN practices were documented smokers and 27% did not have smoking 
status documented. Across the 23 practices, the documented smoking rate averaged 11% (range, 4%–24%). The 
proportion of patients without smoking status documented across the 23 practices averaged 27% (range, 1%–79%).
Neighborhood smoking prevalence
According to the BRFSS, smoking prevalence averaged 13%, ranging from 5% to 26% (Table 2, Figure 1). Partners 
PBRN practices had a market share among adults in the 32 communities that averaged 10%, ranging from 3% to 32% 
(Table 2). Standardizing data according to the demographic makeup of a community resulted in modest changes in the 
estimated smoking prevalence: rates were higher in 16 neighborhoods, lower in 5 neighborhoods, and the same in 11 
neighborhoods. The overall prevalence averaged among neighborhoods remained 11% (range, 5%–22%).
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Factor Surveillance System, 1999–2009. [A tabular version of this figure is also available.]
According to standardized PBRN data, the 32 neighborhoods had an overall smoking prevalence of 11%, ranging from 
5% to 22% (Table 2, Figure 2). Compared with BRFSS estimates, the standardized PBRN estimates averaged 2 
percentage points lower (standard deviation, 3 percentage points), and the differences ranged from −10 percentage 
points (South Boston; 11% PBRN prevalence and 21% BRFSS prevalence; 7% PBRN market share) to +6 percentage 
points (Charlestown; 18% PBRN prevalence and 12% BRFSS prevalence; 32% PBRN market share with a 
neighborhood Community Health Center). The PBRN estimates were lower by more than 5 percentage points in 5 
neighborhoods (Table 2, Figure 3).
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this figure is also available.]
Figure 3. Scatter plot of Practice-Based Research Network (PBRN) smoking prevalence and population-based 
neighborhood prevalence of smoking for 32 Boston neighborhoods (%). [A tabular version of this figure is also 
available.]
Discussion
Neighborhood-level smoking prevalence can be estimated using EHR data from a PBRN, collected in the routine 
course of clinical care. Generally, PBRN estimates were slightly lower than the BRFSS estimates, but they were higher 
in some neighborhoods in which the PBRN had higher market penetration.
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smoking status documented for 100% of patients. Though not directly comparable, our 73% documentation rate 
compares favorably to the BRFSS response rate of 48%, a rate that is declining (10). In addition, clinicians 
preferentially document the smoking status of smokers. Efforts to increase smoking status documentation, including 
local and national incentives and EHR reminders, preferentially add nonsmokers, leading to small changes in the 
measured smoking prevalence. Our previous intervention to increase smoking status documentation served to increase 
the rate of documentation only for patients who were former smokers and never smokers; there was no significant 
change in the proportion of documented smokers (11). The discrepancies between PBRN and BRFSS estimates may 
also be attributable to the differential coverage of the populations by PBRN and BRFSS. Also, our PBRN patient 
population differs from the greater Boston area adult population, the sampling frame for the BRFSS, by having a lower 
percentage of Medicaid beneficiaries, more women than men, and likely healthier or more health-conscious patients 
(12).
Other studies have noted similarities and differences between health system–based and population-based estimates of 
smoking prevalence. A study in Leicester, England, found that General Practice notes, computerized and manual, 
tended to overestimate population smoking prevalence (13). On a larger scale in the UK, a comparison of an EHR-
based PBRN, containing approximately 6% of the UK population, to the population-based General Lifestyle Survey 
showed excellent agreement both nationally and regionally (14,15). However, this analysis is not geographically 
granular enough to allow targeting of neighborhood resources. In the United States, commercial EHRs with broad 
national penetration may have greater potential to make regional and national estimates of acute and chronic 
conditions, as well as behavioral risk factors (16).
Using PBRN or health system data to measure the neighborhood prevalence of smoking offers several advantages over 
traditional, population-based methods. First, the data are already collected as part of routine clinical care, so their 
collection is less expensive than using a separate infrastructure to conduct population-based surveys. Second, for small
-area estimation, as our data show, the sample sizes available in PBRN data are much larger, resulting in smaller 
standard errors (although relative to neighborhood population, even the PBRN estimates might be considered small), 
which may allow for the targeting of community-based interventions in smaller areas than is feasible using the BRFSS. 
Third, given the larger sample size and collection during routine clinical care, the data are potentially more current 
than population-based surveys, for which time is needed for data to become available (14). Fourth, because data were 
taken from an EHR, the potential exists for smoking status to be linked to a richer data set consisting of other 
behaviors, comorbidities, medications, and health outcomes for varied patients (17). Similarly, EHR-based 
measurements can be linked with practice-based treatment interventions (11,18–20). Finally, the emergence and 
implementation of EHR data standards as part of the national Meaningful Use EHR Incentive program will allow for 
information pooling across multiple health systems and encourage routine documentation of smoking status as it did 
for the General Practice pay-for-performance contract in Britain (21). Some of the inherent data problems associated 
with market share of this single PBRN could be resolved by pooling data from multiple health systems.
Despite these advantages to PBRN and health system data, advantages exist to population-based estimates, such as 
those derived from BRFSS. Obviously, despite low and declining response rates, the BRFSS is population-based and 
can provide estimates regardless of whether an individual seeks care through a particular health system or seeks health 
care at all. The BRFSS is not dependent on “market share” to get more accurate estimates, is not dependent on the 
presence of health care facilities in neighborhoods, and is not subject to health system peculiarities that may limit the 
generalizability of PBRN data. Second, although it was not intended to provide the small-scale prevalence we 
calculated, the BRFSS is consistently administered across the United States. Third, the BRFSS potentially provides 
greater consistency over time. Although standards are emerging for the structure of EHR data, the BRFSS data are 
collected with greater attention to consistency in definitions and measurement. Population-based surveys are not free 
from bias, however. For example, smokers generally have lower response rates to surveys than do nonsmokers (13). 
Finally, patients may be more likely to report negative health behaviors like smoking to health care providers than via a 
population survey.
Our analysis suggests that PBRNs and health system data can be used to guide community resources to neighborhoods 
with greater need. However, an understanding of the limitations of estimates derived from nonpopulation-based 
sources, for example, data from a single health system with low market penetration, cannot be used for small-area 
estimation, because the results are potentially biased because of insufficient population coverage and selection bias.
The true public health benefit of using health system–based risk factor information will come from combining data 
from multiple health systems, which requires a change in view of health system data as a public health resource. A 
convergence of health system data with population-based results should be seen more often as documentation 
improves (14). Health system data could be part of a systematic surveillance system that would help in understanding 
the effectiveness of tobacco control programs (22), particularly with mandated reporting of behavioral risk factors such 
as tobacco use, obesity, alcohol use, and others (23). Such a system could afford greater opportunity for collaboration 
and synergy between health care systems, public health departments, community organizations, and other community
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and the health system to take a greater stake in the surrounding community.
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Tables 
 
Table 1. Patient Characteristics Derived From Population-Based Data and 
Practice-Based Research Network Data, 32 Neighborhoods in Boston, 
Massachusetts
Characteristic
2000 Census Practice-Based Research Network
N (%)
Total 877,943 (100) 77,516 (100)
Age, y
18–39 457,634 (52) 27,629 (36)
40–59 253,104 (29) 28,705 (37)
60–79 128,800 (15) 17,074 (22)
≥80 38,405 (4) 4,108 (5)
Sex
Female 463,807 (53) 47,831(62)
Male 414,136 (47) 29,685 (38)
Race/ethnicity
White 570,879 (65) 44,877 (58)
Black 114,940 (13) 8,449 (11)
Latino 83,701 (10) 15,272 (20)
Other 108,423 (12) 8,918 (12)
Language
English 712,249 (69) 63,463 (82)
Spanish 108,275 (10) 9,401 (12)
a
a
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2000 Census Practice-Based Research Network
N (%)
Other 212,334 (21) 4,652 (6)
 Language was available for the census only for the population age 5 or older. Total N for census language data was 
1,032,858.
 
Table 2. Smoking Prevalence Estimated From the Behavioral Risk Factor 
Surveillance System and the Partners Primary Care Practice-Based Research 
Network, 32 Neighborhoods in Boston, Massachusetts
Community 
Name
Adult 
Population
Population-Based 
Estimates Practice-Based Research Network Percentage 
Point 
Difference in 
Standardized 
Population 
Estimates
N 
(1999 
to 
2009)
Smoking 
Prevalence, 
% (95% 
CI)
N 
(2009)
Market 
Share,
%
Crude 
Smoking 
Prevalence,
% (95% CI)
Standardized 
Smoking 
Prevalence,  
% (95% CI)
South Boston 24,569 872 21 (19–24) 1,723 7 12 (10–13) 11 (9–13) −10
Cambridge 
(141)
10,204 85 15 (13–18) 495 5 8 (6–10) 8 (5–11) −
Quincy (169) 42,855 536 19 (16–21) 1,190 3 12 (10–14) 12 (10–15) −
North 
Dorchester
24,343 686 18 (16–21) 1,257 5 13 (11–15) 12 (10–14) −
South End 37,451 1,310 15 (14–17) 3,009 8 10 (9–11) 10 (9–11) −
Revere 37,363 426 26 (23–29) 7,960 21 20 (19–21) 22 (21–23) −
Cambridge 
(140)
13,907 218 9 (8–11) 638 5 5 (3–7) 6 (4–8) −
Back 
Bay/Beacon Hill
4143 394 12 (10–14) 714 17 8 (6–10) 9 (7–11) −
Chelsea 25,512 276 21 (18–24) 6,113 24 15 (14–15) 18 (16–20) −
Quincy 
(170/171)
29,789 336 14 (12–16) 970 3 10 (9–12) 11 (8–13) −
Needham 29,589 389 8 (6–9) 2,393 8 5 (4–6) 5 (4–6) −
West Roxbury 19,741 911 15 (13–16) 3,126 16 11 (10–12) 12 (10–14) −
South 
Dorchester
53,044 1,731 16 (14–17) 2,768 5 13 (12–14) 13 (12–15) −
Brookline 46,737 799 8 (7–10) 3,949 8 6 (6–7) 7 (6–8) −
Cambridge 
(139/142)
31,839 406 11 (9–12) 1,457 5 8 (7–10) 9 (7–11) −
Fenway-
Kenmore
45,724 776 12 (11–14) 1,763 4 11 (10–13) 11 (9–13) −
East Boston 29,364 935 17 (16–19) 2,182 7 17 (15–19) 16 (13–20) −
Cambridge 
(138)
31,989 401 7 (6–9) 1,124 4 6 (5–7) 6 (5–8) −
Roxbury 32,908 1,060 17 (16–19) 3,100 9 16 (15–18) 17 (15–18) −
Malden 45,102 469 19 (17–22) 2,471 5 16 (15–17) 18 (16–20) −
Newton 
(462/466)
6,834 104 7 (6–8) 430 6 6 (4–8) 6 (4–8) −
a
a
a b
c
d e  f
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Community 
Name
Adult 
Population
Population-Based 
Estimates Practice-Based Research Network Percentage 
Point 
Difference in 
Standardized 
Population 
Estimates
N 
(1999 
to 
2009)
Smoking 
Prevalence, 
% (95% 
CI)
N 
(2009)
Market 
Share,
%
Crude 
Smoking 
Prevalence,
% (95% CI)
Standardized 
Smoking 
Prevalence,  
% (95% CI)
Allston/Brighton 60,028 1,363 12 (11–14) 1,968 3 11 (9–12) 11 (9–14) −
Mattapan 19,623 495 14 (12–16) 1,335 7 12 (10–14) 13 (9–17)
Central Boston 19,332 677 9 (8–10) 2,547 13 9 (8–10) 8 (7–10)
Newton 
(459/467)
23,042 536 6 (5–7) 3,274 14 5 (4–6) 6 (5–7)
Newton 
(460/465)
15,927 289 7 (6–8) 1,281 8 6 (5–8) 8 (5–10)
Newton (458) 9,783 148 7 (6–9) 1,019 10 8 (6–9) 8 (6–11)
Newton 
(461/464/468)
11,299 223 5 (4–6) 1,036 9 7 (5–8) 7 (5–9)
Roslindale 24,474 905 13 (11–14) 3,375 14 14 (13–15) 15 (14–17)
Hyde Park 20,911 774 15 (13–17) 3,182 15 15 (14–16) 18 (16–20)
Jamaica Plain 38,146 1,402 11 (10–13) 5,665 15 14 (13–15) 15 (13–16)
Charlestown 12,371 543 12 (11–14) 4,015 32 19 (17–20) 18 (16–20)
Total or 
average
877,943 20,475 13 77,529 10 11 11 −
Abbreviation: CI, confidence interval. 
 Numbers following community names represent zip codes, which have a leading “02” omitted. 
 Adult population estimates derived from the 2000 US Census. 
 Population-based estimates derived from the Behavioral Risk Factor Surveillance System. 
 Market share was calculated by dividing the number of Practice-Based Research Network patients by the census 
population aged 18 years or older in that neighborhood. 
 Crude smoking prevalence was calculated by dividing the number of smokers by the total number of patients in each 
neighborhood. 
 Standardized smoking prevalence was calculated by standardizing the age, sex, and race/ethnicity of Practice Based 
Research Network patients according to the neighborhood makeup according to the 2000 Census.
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